Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP991664.RA-DFx-cdnTCb7R-AHLoRuY1u7uEN3tyfE_Gp7y9XXOhc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP991664.RA-DFx-cdnTCb7R-AHLoRuY1u7uEN3tyfE_Gp7y9XXOhc130_assertion type Assertion NP991664.RA-DFx-cdnTCb7R-AHLoRuY1u7uEN3tyfE_Gp7y9XXOhc130_head.
- NP991664.RA-DFx-cdnTCb7R-AHLoRuY1u7uEN3tyfE_Gp7y9XXOhc130_assertion description "[Ecallantide is a potent and specific plasma kallikrein inhibitor approved for the treatment of acute attacks of HAE affecting any anatomic site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991664.RA-DFx-cdnTCb7R-AHLoRuY1u7uEN3tyfE_Gp7y9XXOhc130_provenance.
- NP991664.RA-DFx-cdnTCb7R-AHLoRuY1u7uEN3tyfE_Gp7y9XXOhc130_assertion evidence source_evidence_literature NP991664.RA-DFx-cdnTCb7R-AHLoRuY1u7uEN3tyfE_Gp7y9XXOhc130_provenance.
- NP991664.RA-DFx-cdnTCb7R-AHLoRuY1u7uEN3tyfE_Gp7y9XXOhc130_assertion SIO_000772 22149337 NP991664.RA-DFx-cdnTCb7R-AHLoRuY1u7uEN3tyfE_Gp7y9XXOhc130_provenance.
- NP991664.RA-DFx-cdnTCb7R-AHLoRuY1u7uEN3tyfE_Gp7y9XXOhc130_assertion wasDerivedFrom befree-20150227 NP991664.RA-DFx-cdnTCb7R-AHLoRuY1u7uEN3tyfE_Gp7y9XXOhc130_provenance.
- NP991664.RA-DFx-cdnTCb7R-AHLoRuY1u7uEN3tyfE_Gp7y9XXOhc130_assertion wasGeneratedBy ECO_0000203 NP991664.RA-DFx-cdnTCb7R-AHLoRuY1u7uEN3tyfE_Gp7y9XXOhc130_provenance.